{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:16:41Z","timestamp":1763036201229},"reference-count":101,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.cld.2006.05.011","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T15:10:36Z","timestamp":1168441836000},"page":"219-237","source":"Crossref","is-referenced-by-count":20,"title":["Alcoholic Hepatitis"],"prefix":"10.1016","volume":"10","author":[{"given":"David A.","family":"Sass","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Obaid S.","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cld.2006.05.011_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/jhep.2002.34734","article-title":"Burden of liver disease in the United States: summary of a workshop","volume":"36","author":"Kim","year":"2002","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2006.05.011_bib2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1046\/j.1360-0443.2002.00184.x","article-title":"Alcohol dependence: a public health perspective","volume":"97","author":"Caetano","year":"2002","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.cld.2006.05.011_bib3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1053\/jhep.2003.50049","article-title":"Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease","volume":"37","author":"Vidali","year":"2003","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2006.05.011_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jhep.2004.04.028","article-title":"Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis","volume":"41","author":"Spahr","year":"2004","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2006.05.011_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.20021","article-title":"Oxidative stress as a trigger for cellular immune responses in patients with alcoholic liver disease","volume":"39","author":"Stewart","year":"2004","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2006.05.011_bib6","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1053\/he.2000.5373","article-title":"Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease","volume":"31","author":"Rolla","year":"2000","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cld.2006.05.011_bib7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S1471-4914(01)02096-2","article-title":"Alcoholic liver disease: new insights into mechanisms and preventative strategies","volume":"7","author":"Stewart","year":"2001","journal-title":"Trends Mol Med"},{"issue":"1","key":"10.1016\/j.cld.2006.05.011_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cld.2004.11.001","article-title":"Morphology of alcoholic liver disease","volume":"9","author":"Lefkowitch","year":"2005","journal-title":"Clin Liver Dis"},{"issue":"5","key":"10.1016\/j.cld.2006.05.011_bib9","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/j.1530-0277.1994.tb00088.x","article-title":"Carbohydrate-deficient transferrin and other markers of high alcohol consumption: a study of 502 patients admitted consecutively to a medical department","volume":"18","author":"Bell","year":"1994","journal-title":"Alcohol Clin Exp Res"},{"issue":"11","key":"10.1016\/j.cld.2006.05.011_bib10","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/BF01324898","article-title":"The SGOT\/SGPT ratio\u2014an indicator of alcoholic liver disease","volume":"24","author":"Cohen","year":"1979","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2006.05.011_bib11","first-page":"718","article-title":"Elevated SGOT\/SGPT ratio in alcoholic patients with acetaminophen toxicity","volume":"79","author":"Himmelstein","year":"1984","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2006.05.011_bib12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1521-6918(03)00053-2","article-title":"Advances in alcoholic liver disease","volume":"17","author":"Arteel","year":"2003","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"17","key":"10.1016\/j.cld.2006.05.011_bib13","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1001\/archinte.1995.00430170103013","article-title":"Screening for excessive alcohol drinking. Comparative value of carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume","volume":"155","author":"Yersin","year":"1995","journal-title":"Arch Intern Med"},{"issue":"23","key":"10.1016\/j.cld.2006.05.011_bib14","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM198412063112302","article-title":"Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone","volume":"311","author":"Mendenhall","year":"1984","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.cld.2006.05.011_bib15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199202203260802","article-title":"A randomized trial of prednisolone in patients with severe alcoholic hepatitis","volume":"326","author":"Ramond","year":"1992","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2006.05.011_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2006.05.011_bib17","doi-asserted-by":"crossref","unstructured":"Carithers RL JR, Herlong HF, Diehl AM, et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med 1989;110(9):685\u201390.","DOI":"10.7326\/0003-4819-110-9-685"},{"issue":"1","key":"10.1016\/j.cld.2006.05.011_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cld.2004.11.004","article-title":"Treatment of alcoholic hepatitis","volume":"9","author":"O'Shea","year":"2005","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2006.05.011_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1600-0676.1994.tb00053.x","article-title":"The arterial blood ketone body ratio as a possible marker of multi-organ failure in patients with alcoholic hepatitis","volume":"14","author":"Saibara","year":"1994","journal-title":"Liver"},{"issue":"1","key":"10.1016\/j.cld.2006.05.011_bib20","first-page":"55","article-title":"Coagulation factors V and VIII in relation to severity and outcome in acute alcoholic hepatitis","volume":"27","author":"Pereira","year":"1992","journal-title":"Alcohol Alcohol"},{"issue":"5","key":"10.1016\/j.cld.2006.05.011_bib21","first-page":"547","article-title":"Increased plasma interleukin-6 concentrations in alcoholic hepatitis","volume":"119","author":"Hill","year":"1992","journal-title":"J Lab Clin Med"},{"issue":"2","key":"10.1016\/j.cld.2006.05.011_bib22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0168-8278(97)80042-6","article-title":"Serum intercellular adhesion molecule-1 in alcoholic liver disease and its relationship with histological disease severity","volume":"26","author":"Douds","year":"1997","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2006.05.011_bib23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/hep.1840120213","article-title":"Predictive value of whole blood chemiluminescence in patients with alcoholic hepatitis","volume":"12","author":"Lunel","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.011_bib24","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the esophagus for bleeding varices","volume":"60","author":"Pugh","year":"1983","journal-title":"Br J\u00a0Surg"},{"issue":"6","key":"10.1016\/j.cld.2006.05.011_bib25","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/hep.1840030602","article-title":"Assessment of prognostic factors in alcoholic liver disease: toward a global quantitative expression of severity","volume":"3","author":"Orrego","year":"1983","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.011_bib26","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1053\/gast.1996.v110.pm8964410","article-title":"Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone","volume":"110","author":"Mathurin","year":"1996","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.cld.2006.05.011_bib27","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1572-0241.1998.00587.x","article-title":"Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology","volume":"93","author":"McCullough","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2006.05.011_bib28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/hep.510250208","article-title":"Neural networks as predictors of outcomes in alcoholic patients with severe liver disease","volume":"25","author":"Lapuerta","year":"1997","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2006.05.011_bib29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00004836-200405000-00012","article-title":"The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis","volume":"38","author":"Kulkarni","year":"2004","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2006.05.011_bib30","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/he.2000.5852","article-title":"A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts","volume":"31","author":"Malinchoc","year":"2000","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2006.05.011_bib31","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.011_bib32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-230X-2-2","article-title":"Utility of the Mayo End-stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis","volume":"2","author":"Sheth","year":"2002","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2006.05.011_bib33","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0168-8278(04)00064-9","article-title":"Model for End stage Liver Disease score predicts mortality across a broad spectrum of liver disease","volume":"40","author":"Said","year":"2004","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2006.05.011_bib34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2006.05.011_bib35","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2004.12.022","article-title":"MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis","volume":"42","author":"Srikureja","year":"2005","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2006.05.011_bib36","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jhep.2005.06.023","article-title":"Prognostic evaluation of alcoholic hepatitis","volume":"43","author":"Forrest","year":"2005","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2006.05.011_bib37","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2004.050781","article-title":"Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score","volume":"54","author":"Forrest","year":"2005","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.cld.2006.05.011_bib38","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1053\/jhep.2003.09038","article-title":"Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone","volume":"38","author":"Mathurin","year":"2003","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2006.05.011_bib39","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00042737-200507000-00011","article-title":"Bilirubin response to corticosteroids in severe alcoholic hepatitis","volume":"17","author":"Morris","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4 Suppl. 1","key":"10.1016\/j.cld.2006.05.011_bib40","first-page":"274","article-title":"A prognostic model predicting the death at 6 months of patients with severe alcoholic hepatitis","volume":"40","author":"Louvet","year":"2004","journal-title":"Hepatology"},{"issue":"4 Suppl. 1","key":"10.1016\/j.cld.2006.05.011_bib41","first-page":"492","article-title":"Prognostic functions: useful tools to predict short-term survival of patients with severe alcoholic hepatitis treated with corticosteroids","volume":"42","author":"Louvet","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2006.05.011_bib42","first-page":"515","article-title":"Natural history of alcoholic hepatitis II. The long-term prognosis","volume":"56","author":"Alexander","year":"1971","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.cld.2006.05.011_bib43","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/oxfordjournals.aje.a116433","article-title":"Alcohol, smoking, coffee, and cirrhosis","volume":"136","author":"Klatsky","year":"1992","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.cld.2006.05.011_bib44","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF01719277","article-title":"The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease","volume":"10","author":"Corrao","year":"1994","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"10.1016\/j.cld.2006.05.011_bib45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0002-9343(84)90776-9","article-title":"Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis","volume":"76","author":"Mendenhall","year":"1984","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.cld.2006.05.011_bib46","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.1840170407","article-title":"A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study","volume":"17","author":"Mendenhall","year":"1993","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2006.05.011_bib47","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1530-0277.1995.tb01560.x","article-title":"Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies","volume":"19","author":"Mendenhall","year":"1995","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"10.1016\/j.cld.2006.05.011_bib48","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-2007-1007349","article-title":"Nutritional therapy in alcoholic liver disease","volume":"13","author":"Schenker","year":"1993","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2006.05.011_bib49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/jhep.2000.8627","article-title":"Short- and long-term outcome of severe alcohol-induced hepatitis with steroids or enteral nutrition: a multicenter randomized trial","volume":"32","author":"Cabre","year":"2000","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2006.05.011_bib50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.7326\/0003-4819-113-4-299","article-title":"Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials","volume":"113","author":"Imperiale","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2006.05.011_bib51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/gut.37.1.113","article-title":"Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables","volume":"37","author":"Christensen","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.cld.2006.05.011_bib52","first-page":"223","article-title":"Place de la corticotherapie dans le traitement des hepatites alcooliques aigues. Resultats d'une meta-analyse","volume":"15","author":"Daures","year":"1991","journal-title":"Gastroenterol Clin Biol"},{"issue":"4","key":"10.1016\/j.cld.2006.05.011_bib53","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0168-8278(01)00289-6","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (alcoholic hepatitis): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe alcoholic hepatitis","volume":"36","author":"Mathurin","year":"2002","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2006.05.011_bib54","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2006.05.011_bib55","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0168-8278(02)00230-1","article-title":"Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study","volume":"37","author":"Spahr","year":"2002","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2006.05.011_bib56","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0168-8278(02)00442-7","article-title":"Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis","volume":"38","author":"Tilg","year":"2003","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2006.05.011_bib57","first-page":"698","article-title":"Open label pilot study of the effects of a chimeric anti-tumor necrosis factor monoclonal antibody in patients with severe acute alcoholic hepatitis","volume":"34","author":"Fong","year":"2001","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2006.05.011_bib58","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2006.05.011_bib59","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1572-0241.2004.04034.x","article-title":"A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis","volume":"99","author":"Menon","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2006.05.011_bib60","first-page":"545","article-title":"Treatment of alcoholic hepatitis with intravenous N-acetylcysteine: a pilot trial","volume":"120","author":"Le Moine","year":"2001","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2006.05.011_bib61","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0016-5085(01)82710-4","article-title":"A single center's experience with acute alcoholic steatohepatitis: corticosteroids compared to combination ursodeoxycholic acid, vitamin C and vitamin E","volume":"120","author":"Cox","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2006.05.011_bib62","first-page":"250","article-title":"Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis","volume":"34","author":"Phillips","year":"2001","journal-title":"Hepatology"},{"issue":"Suppl","key":"10.1016\/j.cld.2006.05.011_bib63","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0168-8278(02)80041-1","article-title":"A trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis","volume":"36","author":"Stewart","year":"2002","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2006.05.011_bib64","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0168-8278(98)80285-7","article-title":"Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial","volume":"28","author":"Pares","year":"1998","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2006.05.011_bib65","first-page":"120","article-title":"Treatment of alcoholic hepatitis with silymarin. A\u00a0double-blind comparative study in 116 patients","volume":"13","author":"Trinchet","year":"1989","journal-title":"Gastroenterol Clin Biol"},{"issue":"1","key":"10.1016\/j.cld.2006.05.011_bib66","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0016-5085(79)80136-5","article-title":"Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease","volume":"76","author":"Orrego","year":"1979","journal-title":"Gastroenterology"},{"issue":"5 Pt 1","key":"10.1016\/j.cld.2006.05.011_bib67","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0016-5085(82)80257-6","article-title":"Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis","volume":"82","author":"Halle","year":"1982","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2006.05.011_bib68","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1034\/j.1600-0676.2001.210606.x","article-title":"Meta-analysis of propylthiouracil for alcoholic liver disease\u2014a Cochrane Hepato-Biliary Group Review","volume":"21","author":"Rambaldi","year":"2001","journal-title":"Liver"},{"issue":"3","key":"10.1016\/j.cld.2006.05.011_bib69","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0016-5085(90)90973-5","article-title":"Failure of colchicine to improve short-term survival in patients with alcoholic hepatitis","volume":"99","author":"Akriviadis","year":"1990","journal-title":"Gastroenterology"},{"issue":"6\u20137","key":"10.1016\/j.cld.2006.05.011_bib70","first-page":"551","article-title":"Treatment of alcoholic hepatitis with colchicine. Results of a randomized double blind trial","volume":"13","author":"Trinchet","year":"1989","journal-title":"Gastroenterol Clin Biol"},{"issue":"3","key":"10.1016\/j.cld.2006.05.011_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002148","article-title":"Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis","author":"Rambaldi","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"issue":"3\u20134","key":"10.1016\/j.cld.2006.05.011_bib72","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000197590","article-title":"Preliminary observations of d-penicillamine therapy in acute alcoholic liver disease","volume":"11","author":"Resnick","year":"1974","journal-title":"Digestion"},{"issue":"6","key":"10.1016\/j.cld.2006.05.011_bib73","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/0016-5085(81)90250-X","article-title":"A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: progress report in 50 patients","volume":"80","author":"Baker","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2006.05.011_bib74","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0168-8278(87)80577-9","article-title":"A prospective multicenter study of insulin and glucagon infusion in acute alcoholic hepatitis","volume":"5","author":"Feher","year":"1997","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2006.05.011_bib75","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/hep.1840150115","article-title":"Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: a multicenter sequential trial","volume":"15","author":"Trinchet","year":"1992","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2006.05.011_bib76","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/hep.1840140625","article-title":"Insulin and glucagon infusion in acute alcoholic hepatitis: a prospective randomized controlled trial","volume":"14","author":"Bird","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.011_bib77","first-page":"1154","article-title":"Insulin and glucagon infusion in acute alcoholic hepatitis","volume":"82","author":"Radvan","year":"1982","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2006.05.011_bib78","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0168-8278(88)80005-9","article-title":"Randomised controlled double-blind trial of\u00a0the\u00a0calcium channel antagonist amlodipine in the treatment of acute alcoholic hepatitis","volume":"28","author":"Bird","year":"1998","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.cld.2006.05.011_bib79","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/gut.19.12.1131","article-title":"Oral prednisone for chronic active liver disease: dose responses and bioavailability studies","volume":"19","author":"Uribe","year":"1978","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.cld.2006.05.011_bib80","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.1840090302","article-title":"Increased tumor necrosis factor production by monocytes in alcoholic hepatitis","volume":"9","author":"McClain","year":"1989","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2006.05.011_bib81","doi-asserted-by":"crossref","first-page":"917","DOI":"10.7326\/0003-4819-112-12-917","article-title":"Increased plasma tumor necrosis factor in severe alcoholic hepatitis","volume":"112","author":"Bird","year":"1990","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.cld.2006.05.011_bib82","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.510260119","article-title":"Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis","volume":"26","author":"Grove","year":"1997","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2006.05.011_bib83","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/hep.1840180316","article-title":"Increased plasma interleukin-8 concentrations in alcoholic hepatitis","volume":"18","author":"Hill","year":"1993","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2006.05.011_bib84","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0016-5085(99)70354-9","article-title":"Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice","volume":"117","author":"Yin","year":"1999","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2006.05.011_bib85","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/hep.510260621","article-title":"Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat","volume":"26","author":"Iimuro","year":"1997","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2006.05.011_bib86","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/hep.20267","article-title":"Infliximab and prednisolone: too much of a good thing?","volume":"39","author":"McClain","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2006.05.011_bib87","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/hep.20344","article-title":"Infliximab and alcoholic hepatitis","volume":"40","author":"Mookerjee","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.011_bib88","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/bj1340523","article-title":"Metabolic alteration produced in liver by chronic ethanol administration: comparison between the effects produced by ethanol and by thyroid hormones","volume":"134","author":"Israel","year":"1973","journal-title":"Biochem J"},{"key":"10.1016\/j.cld.2006.05.011_bib89","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1073\/pnas.72.3.1157","article-title":"Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon","volume":"72","author":"Baker","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.cld.2006.05.011_bib90","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/hep.510240217","article-title":"Nimodipine a dihydropyridine-type calcium channel blocker, prevents alcoholic hepatitis caused by chronic intragastric ethanol exposure in the rat","volume":"24","author":"Iimuro","year":"1996","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2006.05.011_bib91","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0741-8329(02)00224-0","article-title":"S-Adenosylmethionine, cytokines, and alcoholic liver disease","volume":"27","author":"McClain","year":"2002","journal-title":"Alcohol"},{"issue":"1","key":"10.1016\/j.cld.2006.05.011_bib92","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/01.ALC.0000108654.77178.03","article-title":"Abnormal hepatic methionine and glutathione metabolism in patients with alcoholic hepatitis","volume":"28","author":"Lee","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"10.1016\/j.cld.2006.05.011_bib93","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1525-1594.1999.06122.x","article-title":"Molecular Adsorbent Recycling System (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support","volume":"23","author":"Stange","year":"1999","journal-title":"Artif Organs"},{"issue":"1","key":"10.1016\/j.cld.2006.05.011_bib94","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0168-8278(02)00334-3","article-title":"Extracorporeal liver support with Molecular Adsorbent Recirculating System in patients with severe acute alcoholic hepatitis","volume":"38","author":"Jalan","year":"2003","journal-title":"J Hepatol"},{"issue":"8 Suppl","key":"10.1016\/j.cld.2006.05.011_bib95","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1097\/01.ALC.0000078607.32247.9D","article-title":"Severe alcoholic hepatitis successfully treated by leukocytapheresis: a case report","volume":"27","author":"Tsuji","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cld.2006.05.011_bib96","doi-asserted-by":"crossref","unstructured":"Olthoff KM, Brown RS Jr, Delmonico FL, et al. Summary report of a national conference: evolving concepts in liver allocation in the MELD and PELD era. Washington, DC, December 8, 2003. Liver Transpl 2004;10(Suppl 2):A6\u201322.","DOI":"10.1002\/lt.20247"},{"issue":"3","key":"10.1016\/j.cld.2006.05.011_bib97","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/jlts.1997.v3.ajlts0030240","article-title":"Survival and quality of life after liver transplantation for acute alcoholic hepatitis","volume":"3","author":"Shakil","year":"1997","journal-title":"Liver Transpl Surg"},{"issue":"6","key":"10.1016\/j.cld.2006.05.011_bib98","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0168-8278(02)00047-8","article-title":"Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease","volume":"36","author":"Tome","year":"2002","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2006.05.011_bib99","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0168-8278(02)00086-7","article-title":"Is liver transplantation an appropriate treatment for acute alcoholic hepatitis?","volume":"36","author":"Lucey","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2006.05.011_bib100","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/lt.500030305","article-title":"Liver transplantation for alcoholic liver disease: a survey of transplantation programs in the United States","volume":"3","author":"Everhart","year":"1998","journal-title":"Liver Transpl Surg"},{"issue":"Suppl 2","key":"10.1016\/j.cld.2006.05.011_bib101","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/lt.20601","article-title":"Is alcoholic hepatitis an indication for transplantation? Current management and outcomes","volume":"11","author":"Mathurin","year":"2005","journal-title":"Liver Transpl"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326106000134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326106000134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T17:59:58Z","timestamp":1587319198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326106000134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S1089326106000134"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2006.05.011","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}